Invokana (canagliflozin) is a sodium‑glucose co‑transporter‑2 (SGLT‑2) inhibitor used to lower blood glucose in adults with type 2 diabetes. Like all medications, it can cause side effects—most of which are mild and temporary, but a few are more serious. Below is a concise overview of the most commonly reported side effects, the less frequent but important ones, and a few special precautions.
1. Most Common (usually mild) side effects
| Category |
Typical side‑effects |
Why it happens |
| Genital & urinary |
• Vaginal yeast infection (women)
• Penile or perianal rash (men)
• Urinary tract infections (UTIs) |
SGLT‑2 inhibitors increase glucose in the urine, creating a favorable environment for fungi and bacteria. |
| Gastro‑intestinal |
• Nausea, vomiting, diarrhea, abdominal pain |
Changes in glucose excretion can affect gut motility and irritation of the stomach lining. |
| Fluid‑balance |
• Mild dizziness, light‑headedness, or feeling “watery” |
Canagliflozin increases urination (osmotic diuresis), which may lower blood volume or cause transient dehydration. |
| Skin |
• Mild skin rash or itching |
An immune‑mediated reaction or irritation from increased glucose in the urine. |
2. Less Frequent but Important Side Effects
| Category |
Typical side‑effects |
Why it happens |
| Metabolic |
• Hypoglycemia (especially if combined with insulin or sulfonylureas) |
Canagliflozin reduces glucose production, which can lower glucose levels below the usual range. |
| Renal |
• Acute kidney injury or worsening kidney function |
Over‑diuresis or volume depletion can stress kidneys; people with pre‑existing kidney disease are at higher risk. |
| Bone |
• Increased risk of bone fractures (especially with long‑term use) |
SGLT‑2 inhibitors may affect calcium and phosphate balance. |
| Cardiovascular |
• Minor changes in lipid profile (increase in LDL & HDL) |
The drug shifts energy metabolism; most patients have a net cardiovascular benefit, but lipid changes have been noted. |
| Adrenal |
• Euglycemic diabetic ketoacidosis (DKA) |
Rare but serious; can occur with low carbohydrate intake, infections, or major illness, and presents with normal or near‑normal blood glucose but high ketones. |
3. Serious (but rare) side effects
| Category |
Typical side‑effects |
Why it happens |
| Allergic reactions |
• Anaphylaxis, severe rash, swelling of lips/face/tongue, shortness of breath |
Severe hypersensitivity to the drug. |
| Severe genital infections |
• Extensive or invasive candida infection, possible sepsis |
Rarely the infection can spread beyond the genital tract. |
| Severe dehydration |
• Hypotension, fainting, kidney injury |
Over‑diuresis, especially in hot climates or with concurrent diuretics. |
4. Who Should Be Extra Careful?
| Situation |
Why it’s a concern |
| Pre‑existing kidney disease |
Canagliflozin is cleared renally; it may worsen kidney function or even require dose adjustment or discontinuation. |
| Advanced age |
Elderly patients are more prone to dehydration and hypoglycemia. |
| Pregnancy / Lactation |
Not studied in humans; avoid if possible. |
| Concurrent diuretics |
Adds to volume depletion risk. |
| Low carbohydrate or very low insulin state |
Increases risk of euglycemic DKA. |
5. Practical Tips to Minimize Side‑Effects
- Hydrate: Drink plenty of fluids, especially when starting the medication.
- Monitor blood glucose: If you’re on insulin or sulfonylureas, check glucose more frequently and adjust doses if necessary.
- Watch for genital symptoms: Treat yeast infections promptly with OTC antifungal creams or seek a prescription.
- Check kidney function: Your doctor will monitor serum creatinine and eGFR at baseline and during therapy.
- Be alert for DKA: Symptoms include nausea, vomiting, abdominal pain, rapid breathing, or feeling “off” despite normal glucose; seek immediate medical attention if you suspect DKA.
6. Bottom Line
Invokana is generally well tolerated and offers meaningful glycemic control for many people with type 2 diabetes. The most common side effects—genital infections, mild GI upset, and a slight increase in urination—are usually manageable. Rare but serious risks include dehydration, acute kidney injury, hypoglycemia (especially with other glucose‑lowering drugs), and euglycemic DKA.
If you’re considering or already taking Invokana, keep regular appointments with your healthcare provider, follow their monitoring instructions, and report any unusual symptoms right away.
Disclaimer: This information is for educational purposes only. It does not replace professional medical advice. If you have concerns about side effects or how Invokana interacts with your personal health or other medications, consult your prescribing clinician or pharmacist.